Its a clean, no-fuss formula backed by third-party testing results
Lenzi A, Sgro P, Salacone P, Paoli D, Gilio B, Lombardo F, et al
when used alone it is typically for patients who need the ghrelin-pathway effect without a GHRH analog for a specific clinical reason
"The therapeutic logic of copper chelation therapy is fundamentally incompatible with copper-peptide administration," notes a 2020 review in Metallomics published by the Royal Society of Chemistry [7]
This issue has been attributed to the mode of action of these antagonists: those blocking CAP-, proton-, and heat-induced TRPV1 activation result in hyperthermia, whereas those sparing proton-induced activation do not lead to hyperthermia 33,35
Regular blood glucose monitoring and A1C assessment guide therapy adjustments